share_log

CRISPR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director George Simeon

SEC announcement ·  Jun 1 04:54
Summary by Futu AI
In a recent transaction, George Simeon engaged with CRISPR Therapeutics AG, trading under the symbol CRSP, on May 30, 2024. The details of the transaction, including the number of shares involved and the nature of the transaction, have not been disclosed. As of now, the relationship of George Simeon to the issuer remains unspecified. Investors are advised to note the date of the transaction for their records.
In a recent transaction, George Simeon engaged with CRISPR Therapeutics AG, trading under the symbol CRSP, on May 30, 2024. The details of the transaction, including the number of shares involved and the nature of the transaction, have not been disclosed. As of now, the relationship of George Simeon to the issuer remains unspecified. Investors are advised to note the date of the transaction for their records.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.